These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38757454)

  • 1. "Everyone screens to some extent": Barriers and facilitators of developmental screening among children with sickle cell disease: A mixed methods study.
    Hoyt CR; Luo L; Rice HE; Shivakumar N; Housten AJ; Picinich A; Qashou N; Harris KM; Varughese T; King AA
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31060. PubMed ID: 38757454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental delay in infants and toddlers with sickle cell disease: a systematic review.
    Hoyt CR; Varughese TE; Erickson J; Haffner N; Luo L; L'Hotta AJ; Yeager L; King AA
    Dev Med Child Neurol; 2022 Feb; 64(2):168-175. PubMed ID: 34535892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive validity of developmental screening in young children with sickle cell disease: a longitudinal follow-up study.
    Schatz J; Schlenz AM; Smith KE; Roberts CW
    Dev Med Child Neurol; 2018 May; 60(5):520-526. PubMed ID: 29488622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and facilitators to community acceptability of integrating point-of-care testing to screen for sickle cell disease in children in primary healthcare settings in rural Upper East Region of Northern Ghana.
    Chatio ST; Duah E; Ababio LO; Lister N; Egbujo O; Marfo K; Aborigo R; Ansah P; Odame I
    PLoS One; 2024; 19(5):e0303520. PubMed ID: 38768171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopmental deficits among infants and toddlers with sickle cell disease.
    Glass P; Brennan T; Wang J; Luchtman-Jones L; Hsu L; Bass CM; Rana S; Martin B; Reed C; Cheng YI; Gordeuk V
    J Dev Behav Pediatr; 2013; 34(6):399-405. PubMed ID: 23838585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current developmental screening practices in young children with sickle cell disease.
    Aguwa CJ; Cannon AD; Casella JF; Shapiro BK; Lance EI
    Br J Haematol; 2023 Feb; 200(3):377-380. PubMed ID: 36454537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges to implementation of developmental screening in urban primary care: a mixed methods study.
    Morelli DL; Pati S; Butler A; Blum NJ; Gerdes M; Pinto-Martin J; Guevara JP
    BMC Pediatr; 2014 Jan; 14():16. PubMed ID: 24447411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health status and healthcare use in a national sample of children with sickle cell disease.
    Boulet SL; Yanni EA; Creary MS; Olney RS
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S528-35. PubMed ID: 20331954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
    Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
    MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental Screening in Pediatric Sickle Cell Disease: Disease-Related Risk and Screening Outcomes in 4 Year Olds.
    Schatz J; Schlenz A; Reinman L; Smith K; Roberts CW
    J Dev Behav Pediatr; 2017 Oct; 38(8):654-662. PubMed ID: 28816916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of maternal health education and maternal screening on knowledge and the uptake of infant screening for sickle cell disease in Dar-Es-Salaam, Tanzania; a quasi experimental study.
    Tutuba HJ; Jonathan A; Lloyd W; Masamu U; Marco E; Makani J; Ruggajo P; Kidenya BR; Minja IK; Balandya E
    BMC Public Health; 2023 Jan; 23(1):70. PubMed ID: 36627609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Accuracy of Developmental Screening Questionnaires.
    Sheldrick RC; Marakovitz S; Garfinkel D; Carter AS; Perrin EC
    JAMA Pediatr; 2020 Apr; 174(4):366-374. PubMed ID: 32065615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental Screening and Follow-up by Nurses.
    Lynch BA; Weaver AL; Starr SR; Ytterberg KL; Rostad PV; Hall DJ; Tucker SJ
    MCN Am J Matern Child Nurs; 2015; 40(6):388-93. PubMed ID: 26488856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach.
    Alberts NM; Badawy SM; Hodges J; Estepp JH; Nwosu C; Khan H; Smeltzer MP; Homayouni R; Norell S; Klesges L; Porter JS; Hankins JS
    JMIR Mhealth Uhealth; 2020 May; 8(5):e14884. PubMed ID: 32383683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Neurodevelopmental Delays in Children 0 to 5 Years of Age With Sickle Cell Disease: A Systematic Literature Review.
    Knight LMJ; King AA; Strouse JJ; Tanabe P
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):104-111. PubMed ID: 33560086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: opportunities to improve healthcare quality.
    Raphael JL; Shetty PB; Liu H; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Nov; 51(5):647-51. PubMed ID: 18623200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice Patterns for Addressing Developmental-Behavioral Concerns in Sickle Cell Specialty Care.
    Schlenz AM; Phillips S; Mueller M; Kanter J
    Clin Pract Pediatr Psychol; 2023 Sep; 11(3):280-290. PubMed ID: 37876414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Developmental Delay and Contributing Factors Among Children With Sickle Cell Disease.
    Drazen CH; Abel R; Gabir M; Farmer G; King AA
    Pediatr Blood Cancer; 2016 Mar; 63(3):504-10. PubMed ID: 26575319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of developmental screening in an urban setting.
    Guevara JP; Gerdes M; Localio R; Huang YV; Pinto-Martin J; Minkovitz CS; Hsu D; Kyriakou L; Baglivo S; Kavanagh J; Pati S
    Pediatrics; 2013 Jan; 131(1):30-7. PubMed ID: 23248223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric hematology providers on referral for transplant evaluation for sickle cell disease: a regional perspective.
    Mikles B; Bhatia M; Oyeku SO; Jin Z; Green NS
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):566-71. PubMed ID: 24633300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.